Cesare Massart

Nous développons une innovation dans les dispositifs de communication alternatifs et augmentés, permettant aux personnes paralysées de pouvoir retrouver la communication grâce à leurs yeux.

MEDICUD is an Italian medical device startup, involved in the wound healing sector. MEDICUD has developed DRYUM, an incisional negative pressure wound therapy system combining gold standard and patient comfort. It is the only ultraportable mechanic system delivering constant negative pressure during the whole treatment. DRYUM is a cost effective system that aims to be the new standard of care in incisional surgery, reducing dramatic complications such as surgical site infection and dehiscence. DRYUM has a reduced ecological impact thanks to the extensive use of bio-sourced polymers and the absence of embedded electronics. DRYUM is now in the clinical phase with in human trials.

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

We unhide the hidden ones This group of business angels is committed to supporting impact-driven and diverse entrepreneurs, with a particular focus on those from difficult backgrounds and suburbs. They recognize that these entrepreneurs often face unique challenges when it comes to accessing capital and support, and they are dedicated to bridging that gap. The groups investment strategy is focused on identifying and supporting businesses that have a strong social or environmental impact, and are led by entrepreneurs who are from underrepresented communities. They seek out entrepreneurs who have a passion for creating positive change and who are committed to making a difference in their communities. In addition to providing capital, the group also offers mentorship and support to the entrepreneurs they invest in. They believe that building strong relationships with their portfolio companies is key to helping them succeed and make a positive impact. The group is deeply committed to promoting diversity and inclusion in the startup ecosystem. They believe that diverse teams and perspectives are essential to driving innovation and creating lasting change. As such, they actively seek out investment opportunities from a wide range of founders and businesses that reflect a variety of backgrounds, experiences, and perspectives. We are lucky to have visionary and successful founding members like : - Paul Lê and Alban Wienkoop, Labellevie.com founders. - Arnaud Mauduit & Raphael Mosca, Partners at Purple (Angel fund of Laurent Ritter) - Racem Flazi, Legal Place CEO and founder - Adrien Miniatti, Omada CEO and founder. - Mehdi El Moutaoukil, account Executive at Snap. - Mathias Mouats, CEO and Cofounder Asap.Work - Hervé Montoute, CEO Tap Nation, FT120 2023 - Anice Chlagou, Managing Partner Letus Private Office - Idir Ait Sit Amer, CEO and Cofounder Tracktor - Baptiste Corval, Cofounder Phoenix - Ahmed Otmane, CEO and founder Kobaltt - Fariha Shah, , CEO Cominty.ai

Based in the heart of Genopole, BioHive is at the forefront of innovation in biotechnology, specializing in the research and development of skin organoid models derived from induced pluripotent stem cells (iPSCs). We provide advanced solutions to the pharmaceutical and cosmetic industries to better understand the molecular interactions with human skin. Our models reduce reliance on animal testing while enhancing the precision of toxicity and efficacy analyses. Our mission: To deliver predictive and physiologically relevant in vitro models, driving innovation in dermatological and therapeutic care.

50 Partners is a leading startup accelerator in France. Cofounded by 50 successful Tech entrepreneurs (BlaBlaCar, Showroomprivee, Le Bon Coin, …), the program provides a few selected startups with high quality mentoring, financing, international connections, networking and office space in central Paris. 50 Partners is a dedicated ecosystem for innovative tech projects, where entrepreneurs, VCs, corporates and industry experts are committed to help startups succeed

Nous développons une innovation dans les dispositifs de communication alternatifs et augmentés, permettant aux personnes paralysées de pouvoir retrouver la communication grâce à leurs yeux.

MEDICUD is an Italian medical device startup, involved in the wound healing sector. MEDICUD has developed DRYUM, an incisional negative pressure wound therapy system combining gold standard and patient comfort. It is the only ultraportable mechanic system delivering constant negative pressure during the whole treatment. DRYUM is a cost effective system that aims to be the new standard of care in incisional surgery, reducing dramatic complications such as surgical site infection and dehiscence. DRYUM has a reduced ecological impact thanks to the extensive use of bio-sourced polymers and the absence of embedded electronics. DRYUM is now in the clinical phase with in human trials.

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.